[go: up one dir, main page]

ZA200904159B - Bisulfite purification of an alpha-keto amide - Google Patents

Bisulfite purification of an alpha-keto amide

Info

Publication number
ZA200904159B
ZA200904159B ZA200904159A ZA200904159A ZA200904159B ZA 200904159 B ZA200904159 B ZA 200904159B ZA 200904159 A ZA200904159 A ZA 200904159A ZA 200904159 A ZA200904159 A ZA 200904159A ZA 200904159 B ZA200904159 B ZA 200904159B
Authority
ZA
South Africa
Prior art keywords
alpha
keto amide
bisulfite
purification
bisulfite purification
Prior art date
Application number
ZA200904159A
Other languages
English (en)
Inventor
George S K Wong
Jeonghan Park
Tetsuo Iwama
Anantha R Sudhakar
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA200904159B publication Critical patent/ZA200904159B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200904159A 2006-12-15 2009-06-12 Bisulfite purification of an alpha-keto amide ZA200904159B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87519506P 2006-12-15 2006-12-15

Publications (1)

Publication Number Publication Date
ZA200904159B true ZA200904159B (en) 2010-03-31

Family

ID=39434141

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200904159A ZA200904159B (en) 2006-12-15 2009-06-12 Bisulfite purification of an alpha-keto amide

Country Status (9)

Country Link
US (1) US8222427B2 (xx)
EP (1) EP2121604A2 (xx)
JP (1) JP5220026B2 (xx)
CN (1) CN101610999A (xx)
AR (1) AR064357A1 (xx)
CA (1) CA2672268A1 (xx)
MX (1) MX2009006477A (xx)
WO (1) WO2008076316A2 (xx)
ZA (1) ZA200904159B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015004685A2 (en) 2013-07-12 2015-01-15 Mylan Laboratories Ltd An improved process for the purification of boceprevir
CN103804445B (zh) * 2013-12-30 2016-01-13 广州自远生物科技有限公司 一种改进的乙酰异戊酰泰乐菌素的制备方法
CN110563670B (zh) * 2019-08-27 2021-09-28 河北威远生物化工有限公司 一种含硫哌嗪衍生物及其应用
CN111269121B (zh) * 2020-03-10 2023-04-07 广州巨元生化有限公司 一种8-氧代-3,7-二甲基-2,6-辛二烯基羧酸酯化合物的纯化方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001276988B2 (en) 2000-07-21 2007-01-25 Dendreon Corporation Peptides as NS3-serine protease inhibitors of hepatitis C virus
WO2002022459A1 (en) 2000-09-15 2002-03-21 Lid Systems A/S A closure system for closing a container
HRP20040552A2 (en) * 2001-11-16 2004-10-31 Ranbaxy Lab Ltd Process for the preparation of crystalline imipenem
AR044694A1 (es) * 2003-06-17 2005-09-21 Schering Corp Proceso y compuestos intermedios para la preparacion de (1r, 2s,5s) - 3 azabiciclo [3,1,0] hexano-2- carboxamida, n- [3- amino-1- (ciclobutilmetil) - 2, 3 - dioxopropil] -3- [ (2s) - 2 - [[ [ 1,1- dimetiletil] amino] carbonilamino] -3,3-dimetil -1- oxobutil]-6,6 dimetilo
WO2005107745A1 (en) 2004-05-06 2005-11-17 Schering Corporation An inhibitor of hepatitis c
HRP20100218T1 (hr) * 2005-01-14 2010-05-31 Schering Corporation Egzo- i dijastereoselektivna sinteza analoga himbacina
BRPI0615029A2 (pt) * 2005-08-19 2009-06-16 Vertex Pharma processos e intermediários

Also Published As

Publication number Publication date
CN101610999A (zh) 2009-12-23
CA2672268A1 (en) 2008-06-26
US8222427B2 (en) 2012-07-17
WO2008076316A2 (en) 2008-06-26
MX2009006477A (es) 2009-06-26
AR064357A1 (es) 2009-04-01
EP2121604A2 (en) 2009-11-25
US20090326244A1 (en) 2009-12-31
WO2008076316A3 (en) 2008-10-09
JP2010513281A (ja) 2010-04-30
JP5220026B2 (ja) 2013-06-26

Similar Documents

Publication Publication Date Title
ZA200802585B (en) Pyridopyrimidinone inhibitors of Pl3Kα
IL190292A0 (en) PYRIDOPYRIMIDINONE INHIBITORS OF P13Ka
EP2172447A4 (en) amide
IL204970A0 (en) Amide compound
IL194114A0 (en) Treatment of cns conditions
HUE039199T2 (hu) Glutaminsav heterodimerjei
SI1928872T1 (sl) Novi sulfonilpiroli kot inhibitorji HDAC
GB0621607D0 (en) Inhibitors of c-Met
PT2102192E (pt) Formas de estado sólido de ilaprazole racémico
ATE509925T1 (de) Substituierte bicyclocarbonsäureamidverbindungen
ZA200903970B (en) Crystalline modification of fipronil
IL198266A0 (en) Crystalline modification of fipronil
GB0608190D0 (en) Method of purification
EP2307442A4 (en) PURIFICATION OF MODIFIED CYTOKINES
ZA200903967B (en) Crystalline modification of fipronil
IL192988A0 (en) Heterobicyclic amide derivatives
ZA200903972B (en) Crystalline modification of fipronil
EP2068783A4 (en) MOVING RANGE DEVICE
ZA200904159B (en) Bisulfite purification of an alpha-keto amide
IL195061A0 (en) Crystalline forms of atorvastatin
FR2896995B1 (fr) Raquette de paddleball
HK1133432A (en) Bisulfite purification of an alpha-keto amide
DK1999128T3 (da) Tetomilast-polymorf
GB0623836D0 (en) Location of sound
ZA200903491B (en) Solid state forms of racemic ilaprazole